Glutamine metabolism gene tag scoring system for predicting prognosis and treatment resistance of hepatocellular carcinoma
A technology for hepatocellular carcinoma and glutamine, applied in genomics, biochemical equipment and methods, and microbial measurement/testing, can solve the problems of lack of quantification, improve prognosis, improve treatment measures, and reduce the efficacy of immunotherapy Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment example
[0054] 1. Extract the RNA components of the collected hepatocellular carcinoma tumor tissue for purification and sequencing,
[0055] Subjects: Patients from The Cancer Genome Atlas (TCGA) were screened as the training set and patients from the International Cancer Genome Consortium (ICGC) as the validation set. The following inclusion criteria were used:
[0056] (1) Sequencing data that can be used for GMScore calculation,
[0057] (2) Pathological diagnosis of HCC,
[0058] (3) No history of radiation therapy, chemotherapy, targeted therapy, immunotherapy or other anticancer drugs (including neoadjuvant therapy) in the past.
[0059] The transcriptome data and corresponding clinical information data of the training set and validation set were obtained, preprocessed, and adjusted to transcriptome data in FPKM format. An external cohort of anti-PD-1 treated melanoma (GSE78220) was used to validate the association of GMScore with immunotherapy outcome.
[0060] 2. Research...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com